Back to ALPMYView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Castration-resistant Prostate Cancer
View Full LandscapeDrug Information
Target Indication
Castration-resistant Prostate Cancer
Clinical Trial
NCT02346578Last updated: 9/4/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Minodronic acid hydratePhase 3
Involutional Osteoporosis
Folinic acid (leucovorin or local equivalent)Phase 3
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
GoserelinPhase 3
Prostate Cancer
G-CSFPhase 3
AML With FLT3 Mutation
ONO-5920Phase 3
Involutional Osteoporosis
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts